J. Liesveld

J. Friedberg, O. Hyrien, L. Constine, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Use of eltrombopag, a thrombopoietin receptor agonist, in post‐transplantation thrombocytopenia

Yuhchyau Chen, J. Bennett, J. Liesveld, 2012, American journal of hematology.

Stem cell homing: From physiology to therapeutics

J. Liesveld, O. Aljitawi, Naman Sharma, 2020, Stem cells.

Clonal Expansion of T/NK-Cells during Tyrosine Kinase Inhibitor Dasatinib Therapy

S. Mustjoki, I. Dybedal, P. Kovanen, 2008 .

Optimal cytokine stimulation for the enhanced generation of leukemic dendritic cells in short-term culture.

J. Liesveld, C. Abboud, N. Panoskaltsis, 2002, Leukemia research.

Cytotoxicity of Algae Extracts on Normal and Malignant Cells

J. Liesveld, K. Rosell, J. Bechelli, 2011, Leukemia research and treatment.

Marrow failure and aging: The role of "Inflammaging".

J. Liesveld, Janice Zhao, Anima Ghimire, 2021, Best practice & research. Clinical haematology.

Concurrent therapy of chronic lymphocytic leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia utilizing CD19-targeted CAR T-cells

M. Sadelain, M. Geyer, J. Liesveld, 2018, Leukemia & lymphoma.

A phase I study using bortezomib with weekly idarubicin for treatment of elderly patients with acute myeloid leukemia.

D. Howard, H. Weiss, J. Liesveld, 2013, Leukemia research.

A phase 2 study of lenalidomide monotherapy in patients with deletion 5q acute myeloid leukemia: Southwest Oncology Group Study S0605.

H. Gundacker, F. Appelbaum, C. Willman, 2011, Blood.

myelogenous leukemia poor-risk and elderly patients with previously untreated acute A phase 2 study of the farnesyltransferase inhibitor tipifarnib in

P. Greenberg, J. Karp, S. Kaufmann, 2010 .

The therapeutic potential of bedside art observation in hematologic cancer inpatients: a randomized controlled pilot study

J. Liesveld, Emily Gore, Susan Dodge-Peters Daiss, 2022, Supportive Care in Cancer.

Providing personalized prognostic information for adult leukemia survivors.

Alan M. Miller, B. Storer, B. George, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Randomized phase 2 trial of pevonedistat plus azacitidine versus azacitidine for higher-risk MDS/CMML or low-blast AML

D. Faller, L. Adès, J. Liesveld, 2021, Leukemia.

Genetic engineering of platelets to neutralize circulating tumor cells.

J. Liesveld, M. King, Jiahe Li, 2016, Journal of controlled release : official journal of the Controlled Release Society.

Improved outcomes in acute myeloid leukemia patients treated with washed transfusions

F. Boscoe, M. Schymura, J. Liesveld, 2017, American journal of hematology.

Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improves Transplant Outcomes in Older MDS Patients.

M. Aljurf, J. Szer, R. Gale, 2021, Transplantation and cellular therapy.

A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Myelodysplastic Syndromes Patients.

R. Vij, W. Wood, M. Aljurf, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Flaming and fanning: The Spectrum of inflammatory influences in myelodysplastic syndromes.

L. Calvi, J. Liesveld, M. Becker, 2019, Blood reviews.

Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome.

Alan M. Miller, R. Vij, W. Wood, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States.

A. Zander, M. Horowitz, J. Liesveld, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bone marrow mesenchymal stem cells from patients with SLE maintain an interferon signature during in vitro culture.

A. McDavid, J. Liesveld, J. Anolik, 2020, Cytokine.

Cytopenia after CAR-T Cell Therapy—A Brief Review of a Complex Problem

J. Liesveld, P. Reagan, N. Sharma, 2022, Cancers.

Patterns and timing of initial relapse in patients subsequently undergoing transplantation for Hodgkin's lymphoma.

J. Friedberg, L. Constine, J. Liesveld, 2009, International journal of radiation oncology, biology, physics.

Late relapses following high-dose autologous stem cell transplantation (HD-ASCT) for Hodgkin's lymphoma (HL) in the ABVD therapeutic era.

J. Friedberg, R. Fisher, L. Constine, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The combination of bendamustine, bortezomib, and rituximab for patients with relapsed/refractory indolent and mantle cell non-Hodgkin lymphoma.

Derick R. Peterson, J. Armitage, J. Vose, 2011, Blood.

lymphoma patients with relapsed/refractory indolent and mantle cell non-Hodgkin The combination of bendamustine, bortezomib, and rituximab for

J. Vose, R. Fisher, S. Grant, 2011 .

Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patients

H. Kantarjian, G. Garcia-Manero, J. Cortes, 2020, Leukemia & lymphoma.

Psychosocial factors and hematopoietic stem cell transplantation: Potential biobehavioral pathways

J. Liesveld, J. Lyness, J. Knight, 2013, Psychoneuroendocrinology.

Targeted therapy for treatment of patients with classical hairy cell leukemia.

J. Liesveld, C. Zent, A. Baran, 2021, Leukemia research.

Targeting of the bone marrow microenvironment improves outcome in a murine model of myelodysplastic syndrome.

L. Calvi, J. Liesveld, M. Becker, 2016, Blood.

Isodicentric Philadelphia chromosomes in imatinib mesylate (Gleevec)-resistant patients.

J. Liesveld, J. O'Malley, M. Iqbal, 2007, Cancer genetics and cytogenetics.

polyclonal rabbit antithymocyte globulin Apoptosis and complement-mediated lysis of myeloma cells by

M. Zand, J. Liesveld, C. Abboud, 2013 .

Involved field radiation after autologous stem cell transplant for diffuse large B-cell lymphoma in the rituximab era.

J. Friedberg, R. Fisher, O. Hyrien, 2010, International journal of radiation oncology, biology, physics.

Soft Tissue Sarcoma in the Setting of Chronic Cutaneous Graft Versus Host Disease After Allogenic Bone Marrow Transplantation

Deepinder P. Singh, L. Constine, J. Liesveld, 2008, Cancer investigation.

Impact of autologous blood transfusion after bone marrow harvest on unrelated donor’s health and outcome: a CIBMTR analysis

M. Norkin, J. Wingard, J. Liesveld, 2020, Bone Marrow Transplantation.

Phase 1/2 study of uproleselan added to chemotherapy in patients with relapsed or refractory acute myeloid leukemia

P. Marlton, D. DeAngelo, J. Liesveld, 2021, Blood.

Expression of integrins and examination of their adhesive function in normal and leukemic hematopoietic cells.

J. Liesveld, C. Abboud, D. Ryan, 1993, Blood.

Improvement in a patient with hypereosinophilic syndrome after initiation of dupilumab treatment

J. Liesveld, G. Scott, L. Beck, 2020, JAAD case reports.

State of the art; the hypereosinophilic syndromes.

J. Liesveld, C. Abboud, 1991, Blood reviews.

Integrins and adhesive receptors in normal and leukemic CD34+ progenitor cells: potential regulatory checkpoints for cellular traffic.

J. Dipersio, J. Liesveld, C. Abboud, 1994, Leukemia & lymphoma.

Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer?

M. Perales, F. Appelbaum, J. Liesveld, 2013, Blood.

Neutrophil-Mediated IFN Activation in the Bone Marrow Alters B Cell Development in Human and Murine Systemic Lupus Erythematosus

J. Liesveld, J. Knight, E. Baechler, 2014, The Journal of Immunology.

Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR® study

E. Guinan, M. Boeckh, M. Aljurf, 2016, Bone Marrow Transplantation.

Cytokine regulation of early human lymphopoiesis.

J. Liesveld, C. Abboud, D. Ryan, 1994, Journal of immunology.

A Phase I trial: dose escalation of melphalan in the "BEAM" regimen using amifostine cytoprotection.

J. Friedberg, L. Constine, J. Liesveld, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Phase II study of a TLR‐9 agonist (1018 ISS) with rituximab in patients with relapsed or refractory follicular lymphoma

Derick R. Peterson, J. Friedberg, R. Fisher, 2009, British journal of haematology.

Mobilization of hematopoietic stem cells.

J. Liesveld, S. Fu, Jane L. Liesveld, 2000, Blood reviews.

Nanoparticle-Coated Microtubes for the Manipulation of Cancer Cells

J. Liesveld, M. King, R. Zhou, 2010 .

Using Protein-Functionalized Microchannels for Stem Cell Separation

J. Liesveld, M. King, Nichola Charles, 2006 .

High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab era

J. Friedberg, L. Constine, J. Liesveld, 2012, Leukemia & lymphoma.

A single-arm pilot study of a mobile health exercise intervention (GO-EXCAP) in older patients with myeloid neoplasms

S. Mohile, J. Liesveld, K. Loh, 2022, Blood advances.

Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies.

M. Norkin, W. Wood, M. Aljurf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Proteasome Inhibition in Myelodysplastic Syndromes and Acute Myelogenous Leukemia Cell Lines

J. Liesveld, Chaohui Lu, K. Rosell, 2011, Cancer investigation.

The Hematopoietic Stem Cell in Myelodysplasia

J. Liesveld, C. Jordan, G. Phillips, 2004, Stem cells.

Characterization of human marrow stromal cells: role in progenitor cell binding and granulopoiesis.

J. Liesveld, C. Abboud, M. Lichtman, 1989, Blood.

Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis

B. Sandmaier, M. Aljurf, R. Gale, 2016, Cancer.

Emergence of JAK2-mutant primary myelofibrosis in myelodysplastic syndrome: rare case report, literature review, and implications for clonal progression

J. Bennett, W. R. Burack, J. Liesveld, 2012, Journal of Hematopathology.

Stem cell factor and stromal cell co-culture prevent apoptosis in a subculture of the megakaryoblastic cell line, UT-7.

J. Liesveld, C. Abboud, A. Harbol, 1996, Leukemia research.

Impact of mobilized blood progenitor cell quality determined by the CFU-GM/CD34+ ratio on rapid engraftment after blood stem cell transplantation.

J. Liesveld, C. Abboud, J. Ifthikharuddin, 2002, Blood cells, molecules & diseases.

The hematopoietic cell transplantation specific comorbidity index and survival after extracorporeal photopheresis, pentostatin, and reduced dose total body irradiation conditioning prior to allogeneic stem cell transplantation.

J. Liesveld, S. Hashmi, M. Becker, 2013, Leukemia research.

Hypereosinophilic syndromes: an update

J. Liesveld, C. Abboud, 1996 .

A phase II study of sequential decitabine and rapamycin in acute myelogenous leukemia.

M. Azadniv, J. Liesveld, M. Becker, 2021, Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis.

CML: Defining the efficacy of targeted therapy with the TARGET system.

J. Liesveld, 2011, Leukemia research.

Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia.

A. Zander, J. Szer, M. Horowitz, 2008, Blood.

Comparison of outcomes of HCT in blast phase of BCR-ABL1- MPN with de novo AML and with AML following MDS.

Y. Liu, M. Aljurf, J. Szer, 2020, Blood advances.

Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy

S. Mustjoki, M. Höglund, I. Dybedal, 2008, Leukemia.

Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation

E. Estey, B. Sandmaier, M. Krem, 2021, Bone Marrow Transplantation.

Intra‐arterial methylprednisolone for the management of steroid‐refractory acute gastrointestinal and hepatic graft versus host disease

J. Friedberg, G. Holland, J. Liesveld, 2011, American journal of hematology.

Mixed chimerism in SCT: conflict or peaceful coexistence?

P. Rothberg, J. Liesveld, Jane L. Liesveld, 2008, Bone Marrow Transplantation.

Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin

J. Liesveld, N. Blumberg, M. Walters, 2005, Bone Marrow Transplantation.

Eltrombopag, a thrombopoietin receptor agonist, enhances human umbilical cord blood hematopoietic stem/primitive progenitor cell expansion and promotes multi-lineage hematopoiesis.

Yuhchyau Chen, J. Liesveld, Y. Tsai, 2012, Stem cell research.

What would Karl Landsteiner do? The ABO blood group and stem cell transplantation

J. Liesveld, N. Blumberg, G. Phillips, 2005, Bone Marrow Transplantation.

Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study

A. Logan, D. Howard, J. Liesveld, 2021, Blood.

CD34+ progenitor cell isolation from blood and marrow: a comparison of techniques for small-scale selection.

J. Dipersio, J. Liesveld, C. Abboud, 1994, Bone marrow transplantation.

Polyclonal Rabbit Antithymocyte Globulin Triggers B-Cell and Plasma Cell Apoptosis by Multiple Pathways

M. Zand, Benjamin J. Briggs, J. Liesveld, 2005, Transplantation.

Involved field radiation therapy following high dose chemotherapy and autologous stem cell transplant benefits local control and survival in refractory or recurrent Hodgkin lymphoma.

J. Friedberg, L. Constine, J. Liesveld, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Adapting a patient-centered communication tool for older patients with acute myeloid leukemia and their oncologist

J. Liesveld, A. El-Jawahri, T. Leblanc, 2022, Blood advances.

Effect of hydrocortisone and interleukins 1 and 2 on eosinophil progenitors in hypereosinophilic states.

J. Liesveld, C. Abboud, J. Rowe, 1988, International journal of cell cloning.

Referral to and receipt of allogeneic hematopoietic stem cell transplantation in older adults with acute myeloid leukemia.

J. Liesveld, M. Becker, R. Burack, 2022, Journal of geriatric oncology.

Outcomes and costs of autologous stem cell mobilization with chemotherapy plus G-CSF versus G-CSF alone

G. Tricot, J. Kanda, J. Liesveld, 2013, Bone Marrow Transplantation.

Maturation-dependent adhesion of human B cell precursors to the bone marrow microenvironment.

J. Liesveld, C. Abboud, D. Ryan, 1990, Journal of immunology.

Late Relapses After High‐dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Diffuse Large B‐cell Lymphoma in the Rituximab Era

J. Friedberg, L. Constine, J. Liesveld, 2017, Clinical lymphoma, myeloma & leukemia.

Mechanisms of cytopenia in human immunodeficiency virus infection.

P. Simpson‐Haidaris, J. Liesveld, C. Abboud, 1994, Blood reviews.

Novel mHealth App to Deliver Geriatric Assessment-Driven Interventions for Older Adults With Cancer: Pilot Feasibility and Usability Study

Rebecca Schnall, Supriya G Mohile, S. Mohile, 2018, JMIR cancer.

A Phase II Study of Lenalidomide for Previously Untreated Deletion (del) 5q Acute Myeloid Leukemia (AML) Patients Age 60 or Older Who Are Not Candidates for Remission Induction Chemotherapy (Southwest Oncology Group Study S0605)

H. Gundacker, F. Appelbaum, C. Willman, 2010 .

Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34+ Yields Are Less.

J. Szer, D. Stroncek, J. Liesveld, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

IFNβ signaling inhibits osteogenesis in human SLE bone marrow

A. McDavid, J. Liesveld, J. Anolik, 2020, Lupus.

A randomized placebo-controlled trial of lisofylline in HLA-identical, sibling-donor, allogeneic bone marrow transplant recipients

J. Singer, J. Bianco, J. Singer, 2000, Bone Marrow Transplantation.

5 Treatment and prognostic factors in acute myeloid leukaemia

J. Liesveld, J. Rowe, 1996 .

Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study.

P. Hari, J. Varni, W. Tse, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allografting in chronic myelogenous leukemia followed by immunotherapy

J. Liesveld, B. Simonsson, J. Rowe, 1993, Stem cells.

25 Dose escalation of consolidation radiation therapy (involved field) following autologous bone marrow transplant for recurrent Hodgkin's disease and lymphoma

R. Brasacchio, P. Rubin, L. Constine, 1996 .

TGF-beta down-regulates stromal IL-7 secretion and inhibits proliferation of human B cell precursors.

J. Liesveld, C. Abboud, J. Tang, 1997, Journal of immunology.

Collection of Peripheral Blood Progenitor Cells in One Day is Associated with Decreased Donor Toxicity compared to Two Days in Unrelated Donors.

J. Wingard, J. Liesveld, T. Spitzer, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduce

N. Geller, P. Hari, D. Porter, 2019, The Lancet. Haematology.

Evolution of acute myelogenous leukemia stem cell properties after treatment and progression.

John M. Ashton, Jason R. Myers, J. Liesveld, 2013, Blood.

A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group.

D. Neuberg, J. Bennett, M. Tallman, 2004, Blood.

The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone.

J. Dipersio, J. Liesveld, S. Devine, 2005, Blood.

Safety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin's lymphoma undergoing stem cell mobilization

A. Nademanee, J. Liesveld, G. Bridger, 2010, Bone Marrow Transplantation.

Clinical factors affecting engraftment and transfusion needs in SCT: a single-center retrospective analysis

O. Hyrien, J. Liesveld, M. Becker, 2013, Bone Marrow Transplantation.

Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia

M. Krem, C. Hourigan, M. Aljurf, 2021, Blood advances.

Phenotypic characterization of the human fibrous histiocytoma giant cell tumor (GCT) cell line and its cytokine repertoire.

J. Liesveld, C. Abboud, J. Gasson, 1993, Experimental hematology.

An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells.

M. Carroll, P. Crooks, J. Bennett, 2007, Blood.

Acute promyelocytic leukemia-mobile and infiltrative.

J. Liesveld, 2007, Leukemia research.

A randomized placebo-controlled trial of lisofylline in HLA-identical, sibling-donor, allogeneic bone marrow transplant recipients. The Lisofylline Marrow Transplant Study Group.

J. Bianco, J. Singer, J. Liesveld, 2000, Bone marrow transplantation.

Autologous stem cell rescue recipient with neutrophil tissue delivery detected prior to blood engraftment: A case report

J. Liesveld, G. Scott, O. Aljitawi, 2020, EJHaem.

Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission.

Alan M. Miller, R. Vij, F. Baron, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome.

John P Klein, Daniel J Weisdorf, Peter Greenberg, 2004, Blood.

Aged marrow macrophages expand platelet-biased hematopoietic stem cells via Interleukin1B.

Michael R. Elliott, John M. Ashton, Jason R. Myers, 2019, JCI insight.

Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data.

Monica L Guzman, M. Carroll, Xiaojie Li, 2008, Blood.

Rapid method for detection of mutations in the nucleophosmin gene in acute myeloid leukemia.

P. Rothberg, J. Liesveld, C. Abboud, 2008, The Journal of molecular diagnostics : JMD.

BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells.

John M. Ashton, J. Liesveld, P. Brookes, 2013, Cell stem cell.

Evolution to plasmablastic lymphoma evades CD19‐directed chimeric antigen receptor T cells

J. Friedberg, D. Porter, P. Rothberg, 2015, British journal of haematology.

Effect of nitric oxide production and oxygen tension on progenitor preservation in ex vivo culture.

J. Liesveld, C. Abboud, S. Reykdal, 1999, Experimental hematology.

Tissue-restricted accumulation of a ribosomal protein mRNA is not coordinated with rRNA transcription and precedes growth of the sea urchin pluteus larva.

P. Kingsley, J. Liesveld, Q. Yang, 1992, Developmental biology.

Expression of interleukin-7 receptor by lineage-negative human bone marrow progenitors with enhanced lymphoid proliferative potential and B-lineage differentiation capacity.

J. Liesveld, C. Abboud, R. Insel, 1997, Blood.

Transitional B cells in quiescent SLE: An early checkpoint imprinted by IFN.

E. Meffre, J. Liesveld, V. Poindron, 2019, Journal of autoimmunity.

SY-1425, a Potent and Selective RARα Agonist, in Combination with Azacitidine Demonstrates a High Complete Response Rate and a Rapid Onset of Response in RARA-Positive Newly Diagnosed Unfit Acute Myeloid Leukemia

P. Fenaux, T. Cluzeau, J. Liesveld, 2020 .

Initial Results from a Biomarker-Directed Phase 2 Trial of SY-1425, a Potent and Selective RARα Agonist, in Combination with Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia

T. Cluzeau, J. Liesveld, P. Rousselot, 2020 .

Acute myelogenous leukemia—microenvironment interactions: Role of endothelial cells and proteasome inhibition

J. Lancet, J. Liesveld, C. Abboud, 2005, Hematology.

ABO identical and washed blood transfusions as candidate strategies to reduce early mortality in acute promyelocytic leukemia.

J. Liesveld, N. Blumberg, C. Aquina, 2017, Leukemia research.

Delivery of apoptotic signal to rolling cancer cells: A novel biomimetic technique using immobilized TRAIL and E‐selectin

J. Liesveld, M. King, K. Rana, 2009, Biotechnology and bioengineering.

Myelogenous Leukemia Cells Metabolism to Eradicate Human Acute Targeting Aberrant Glutathione Molecular Bases of Disease :

Patricia Greninger, J. Settleman, Lei Shi, 2014 .

Targeting Aberrant Glutathione Metabolism to Eradicate Human Acute Myelogenous Leukemia Cells*

John M. Ashton, Patricia Greninger, J. Settleman, 2013, The Journal of Biological Chemistry.

HLA-identical sibling allogeneic transplants versus chemotherapy in acute myelogenous leukemia with t(8;21) in first complete remission: collaborative study between the German AML Intergroup and CIBMTR.

R. Schlenk, H. Döhner, A. Ganser, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A phase 2 study of the farnesyltransferase inhibitor tipifarnib in poor-risk and elderly patients with previously untreated acute myelogenous leukemia.

P. Greenberg, Y. Park, J. Karp, 2007, Blood.

Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial.

J. Karp, S. Kaufmann, J. Wright, 2001, Blood.

Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study.

Alan M. Miller, P. D. Dal Cin, J. Sierra, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas

J. Friedberg, R. Fisher, D. Neuberg, 2009, British journal of haematology.

Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML.

J. Friedberg, J. Liesveld, C. Abboud, 2006, Leukemia research.

Treatment decision-making in acute myeloid leukemia: a qualitative study of older adults and community oncologists

P. Duberstein, S. Mohile, W. Stock, 2020, Leukemia & lymphoma.

MIP-1alpha and TGF-beta production in CD34+ progenitor-stromal cell coculture systems: effects of progenitor isolation method and cell-cell contact.

J. Liesveld, C. Abboud, K. Rosell, 2000, Blood cells, molecules & diseases.

Cytokine effects and role of adhesive proteins and Fc receptors in human macrophage‐mediated antibody dependent cellular cytotoxicity

J. Liesveld, C. Abboud, R. Duerst, 1991, Journal of cellular biochemistry.

Lysis of human fibroblast colony-forming cells and endothelial cells by monoclonal antibody (6-19) and complement.

J. Liesveld, C. Abboud, C. Frantz, 1986, Blood.

Phase I Study of Eltrombopag for Promoting Thrombopoiesis in Patients Undergoing Stem Cell Transplantation After Total Body Irradiation

J. Friedberg, O. Hyrien, L. Constine, 2011 .

ABO incompatibility between donor and recipient and clinical outcomes in allogeneic stem cell transplantation.

J. Liesveld, N. Blumberg, J. Heal, 2003, Leukemia research.

Non-donor specific anti-human leukocyte antigen (HLA) antibodies are not associated with poor outcome in hematopoietic stem cell transplant recipients.

J. Liesveld, M. Becker, A. Baran, 2020, Human immunology.

Platelet transfusion and survival in adults with acute leukemia

J. Liesveld, J. Rowe, N. Blumberg, 2008, Leukemia.

Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection Centers.

J. Wingard, D. Stroncek, J. Liesveld, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Phase II study of combination human recombinant GM‐CSF with intermediate‐dose cytarabine and mitoxantrone chemotherapy in patients with high‐risk myelodysplastic syndromes (RAEB, RAEBT, and CMML): An Eastern Cooperative Oncology Group Study

W. Hiddemann, J. Liesveld, H. Lazarus, 2001, American journal of hematology.

Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: Impact of tyrosine kinase inhibitor and minimal residual disease

M. Norkin, R. Vij, M. Aljurf, 2013, Leukemia.

Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in older adults: Current treatment and novel therapies.

J. Liesveld, K. O'Dwyer, 2017, Best practice & research. Clinical haematology.

Adhesive interactions of normal and leukemic human CD34+ myeloid progenitors: role of marrow stromal, fibroblast, and cytomatrix components.

J. Liesveld, C. Abboud, J. Brennan, 1991, Experimental hematology.

Cell Mobilization is Superior to G-CSF Alone The Use of AMD3100 Plus G-CSF for Autologous Hematopoietic Progenitor

J. Dipersio, J. Liesveld, S. Devine, 2013 .

The Concentration of Total Nucleated Cells in Harvested Bone Marrow for Transplantation Has Decreased over Time.

M. Norkin, J. Szer, J. Liesveld, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Significant Improvements in the Practice Patterns of Adult Related Donor Care in US Transplantation Centers.

M. Norkin, J. Liesveld, Z. DeFilipp, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

P. Hari, W. Tse, M. Horowitz, 2018, Haematologica.

Oral valacyclovir versus intravenous acyclovir in preventing herpes simplex virus infections in autologous stem cell transplant recipients.

J. Lancet, J. Liesveld, C. Abboud, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

NPM 1 Mutations in AML—The Landscape in 2023

J. Liesveld, Naman Sharma, 2023, Cancers.

Circulating endocannabinoids during hematopoietic stem cell transplantation: A pilot study

J. Liesveld, A. Szabo, C. Hillard, 2015, Neurobiology of Stress.

Bone marrow mesenchymal stromal cells from acute myelogenous leukemia patients demonstrate adipogenic differentiation propensity with implications for leukemia cell support

John M. Ashton, Jason R. Myers, M. Azadniv, 2019, Leukemia.

A phase III trial to evaluate the efficacy of uproleselan (GMI-1271) with chemotherapy in patients with relapsed/refractory acute myeloid leukemia.

P. Marlton, D. DeAngelo, J. Liesveld, 2019, Journal of Clinical Oncology.

Investigating the Feasibility of Stem Cell Enrichment Mediated by Immobilized Selectins

J. Liesveld, M. King, Jane L Liesveld, 2007, Biotechnology progress.

Response of human CD34+ cells to CXC, CC, and CX3C chemokines: implications for cell migration and activation.

J. Liesveld, C. Abboud, K. Rosell, 2001, Journal of hematotherapy & stem cell research.

Bortezomib and gemcitabine in relapsed or refractory Hodgkin's lymphoma.

J. Friedberg, R. Fisher, J. Liesveld, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Rapid and selective death of leukemia stem and progenitor cells induced by the compound 4-benzyl, 2-methyl, 1,2,4-thiadiazolidine, 3,5 dione (TDZD-8).

Xiaojie Li, J. Liesveld, J. Hébert, 2007, Blood.

Effects of Neddylation and mTOR Inhibition in Acute Myelogenous Leukemia

M. Azadniv, J. Liesveld, M. Becker, 2019, Translational oncology.

Erythropoietin-receptor expression and function during the initiation of murine yolk sac erythropoiesis.

J. Palis, J. Liesveld, L. Silver, 1997, Experimental hematology.

Allogeneic Hematopoietic Cell Transplantation for Older Adults with Acute Myeloid Leukemia

J. Liesveld, K. Loh, K. O'Dwyer, 2018, Cancers.

A Phase 1/2 Study of Umbralisib, Ublituximab, and Venetoclax (U2-Ven) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

J. Friedberg, J. Liesveld, B. Hill, 2020, Blood.

Prevention of graft versus host disease with Hematopoietic CellTransplantation with Reduced Intensity Conditioning—a comparison of threeprophylaxis regimens (tacrolimus/mycophenolate mofetil/cyclophosphamide,tacrolimus/methotrexate/bortezomib or tacrolimus/methotrexate/maraviroc) versustacrolimus/me

N. Geller, P. Hari, M. Pasquini, 2019 .

Effectiveness and safety of high-dose cyclophosphamide as salvage therapy for high-risk multiple myeloma and plasma cell leukemia refractory to new biological agents

J. Friedberg, G. Holland, J. Liesveld, 2011 .

Late effects after ablative allogeneic stem cell transplantation for adolescent and young adult acute myeloid leukemia.

J. Liesveld, Z. DeFilipp, B. Shaw, 2020, Blood advances.

Modulation of Selectin-Mediated Adhesion of Flowing Lymphoma and Bone Marrow Cells by Immobilized SDF-1

J. Liesveld, M. King, Elizabeth A. Hedges, 2014, International journal of molecular sciences.

Management of AML: who do we really cure?

J. Liesveld, 2012, Leukemia research.

Phenotypic, genotypic, and functional characterization of normal and acute myeloid leukemia-derived marrow endothelial cells.

M. Azadniv, J. Liesveld, M. Coppage, 2016, Experimental Hematology.

Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT

M. Norkin, A. Nagler, J. Szer, 2018, Bone Marrow Transplantation.

The roles of bone remodeling in normal hematopoiesis and age-related hematological malignancies

E. Schwarz, L. Calvi, J. Liesveld, 2023, Bone Research.

Expression and function of adhesion receptors in acute myelogenous leukemia: parallels with normal erythroid and myeloid progenitors.

J. Liesveld, 1997, Acta haematologica.

The effect of using music therapy with relaxation imagery in the management of patients undergoing bone marrow transplantation: a pilot feasibility study.

B. C. Hunter, O. J. Sahler, J. Liesveld, 2003, Alternative therapies in health and medicine.

Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase III, placebo-controlled QUAZAR AML-001 trial

H. Döhner, H. Dombret, B. Skikne, 2021, Haematologica.

Economic and Practical Considerations in the Treatment of Oral Mucosal Chronic Graft-Versus-Host Disease.

J. Liesveld, S. Elad, N. Treister, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Expression of IgG Fc receptors in myeloid leukemic cell lines. Effect of colony-stimulating factors and cytokines.

J. Liesveld, C. Abboud, R. Looney, 1988, Journal of immunology.

Apoptosis and complement-mediated lysis of myeloma cells by polyclonal rabbit antithymocyte globulin.

M. Zand, J. Liesveld, C. Abboud, 2006, Blood.

Outpatient administration of BEAM conditioning prior to autologous stem cell transplantation for lymphoma is safe, feasible, and cost‐effective

J. Friedberg, J. Liesveld, M. Becker, 2016, Cancer medicine.

Targeting RARA overexpression with tamibarotene, a potent and selective RARα agonist, is a novel approach in AML

J. Carulli, M. McKeown, M. Eaton, 2022, Blood advances.

Dueling for dual inhibition: Means to enhance effectiveness of PI3K/Akt/mTOR inhibitors in AML.

J. Liesveld, Lauren Herschbein, 2017, Blood reviews.

Survival after HLA-identical allogeneic peripheral blood stem cell and bone marrow transplantation for hematologic malignancies: meta-analysis of randomized controlled trials

N. B. Lerner, G. Lyman, S. Fisher, 2003, Bone Marrow Transplantation.

The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia.

M. Norkin, B. Sandmaier, B. George, 2019, Blood advances.

Can we incorporate geriatric assessment in the management of acute lymphoblastic leukemia in older adults?

J. Liesveld, K. Loh, K. O'Dwyer, 2018, Journal of geriatric oncology.

J. Sierra, M. Tallman, R. Gale, 2008, Blood.

Peri-Transplant Psychosocial Factors and Neutrophil Recovery following Hematopoietic Stem Cell Transplantation

B. C. Hunter, Yinglin Xia, J. Liesveld, 2014, PloS one.

Mixed lineage acute leukemia: navigating the heterogeneity

J. Liesveld, 2015, European journal of haematology.

Barriers to Hematopoietic Cell Transplantation for Adults in the United States: A Systematic Review with a Focus on Age.

T. Lagu, W. Stock, J. Liesveld, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors.

R. Vij, M. Aljurf, R. Gale, 2022, JAMA oncology.

Phase I study for poor-prognosis lymphoma: augmentation of the "BEAM" regimen with escalating dose melphalan using amifostine cytoprotection and autologous hematopoietic stem cell transplantation--a preliminary report.

J. Friedberg, J. Lancet, J. Liesveld, 2004, Seminars in oncology.

Trouble in the niche? Send in a statin.

J. Liesveld, 2016, Blood.

Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report.

B. Sandmaier, M. Perales, A. Nagler, 2020, Blood advances.

Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review.

J. Bennett, W. R. Burack, J. Liesveld, 2012, Leukemia research.

A phase II study of the farnesyltransferase inhibitor tipifarnib in poor-risk and elderly patients with previously untreated acute myelogenous leukemia

P. Greenberg, Y. Park, J. Karp, 2006 .

Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study

M. Aljurf, J. Szer, R. Gale, 2020 .

Effects of AMD3100 on transmigration and survival of acute myelogenous leukemia cells.

J. Liesveld, C. Abboud, Chaohui Lu, 2007, Leukemia research.

Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adults.

M. Pasquini, K. Ballen, J. Liesveld, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Plerixafor: potential role in acute leukemia therapy

J. Liesveld, 2015 .

Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission.

J. Sierra, A. Zander, M. Horowitz, 2006, Biology of Blood and Marrow Transplantation.

Treatment with AMD3100 in Multiple Myeloma or Non-Hodgkin’s Lymphoma Patients to Increase the Number of Peripheral Blood Stem Cells When Given with a Mobilizing Regimen of Chemotherapy and G-CSF.

A. Nademanee, J. Liesveld, L. Akard, 2004 .

Evolution to Plasmablastic Lymphoma (PBL) after CAR-T Cell Therapy in a Case of SLL/CLL with Richter’s Transformation

D. Porter, P. Rothberg, J. Liesveld, 2014 .

A phase I study of decitabine and rapamycin in relapsed/refractory AML.

J. Liesveld, K. Rosell, C. Jordan, 2013, Leukemia research.

Qualitative Study of Factors That Influence Treatment Decision-Making Among Community Oncologists and Older Patients with Acute Myeloid Leukemia

P. Duberstein, S. Mohile, W. Stock, 2018, Blood.

Patterns and Timing of Failure for Diffuse Large B-Cell Lymphoma After Initial Therapy in a Cohort Who Underwent Autologous Bone Marrow Transplantation for Relapse.

J. Friedberg, L. Constine, J. Liesveld, 2016, International journal of radiation oncology, biology, physics.

CpG Oligonucleotide (1018 ISS) May Overcome Rituximab (R) Resistance in Follicular Lymphoma (FL) through Enhanced ADCC, T Cell Expansion, and Alteration of Tumor Microenvironment.

J. Friedberg, R. Fisher, R. Coffman, 2005 .

Persistence of HIV-1 Env-Specific Plasmablast Lineages in Plasma Cells after Vaccination in Humans

M. Piepenbrink, J. Liesveld, A. Hessell, 2020, Cell reports medicine.

Broad and Protective Influenza B Virus Neuraminidase Antibodies in Humans after Vaccination and their Clonal Persistence as Plasma Cells

M. Piepenbrink, J. Liesveld, A. Nogales, 2019, mBio.

A case of JAK2 positive essential thrombocythemia 16.5 years after autologous marrow transplantation for AML

P. Rothberg, J. Liesveld, A. Walker, 2007, Bone Marrow Transplantation.

Dasatinib/Prednisone Induction Followed by Blinatumomab/Dasatinib in Ph+ Acute Lymphoblastic Leukemia.

B. Wood, S. O'brien, M. Othus, 2022, Blood advances.

Chemo-Mobilization Provides Superior Mobilization and Collection in Autologous Stem Cell Transplants but with Less Predictability and At a Higher Cost,

G. Tricot, J. Kanda, J. Liesveld, 2011 .

Maintenance tyrosine kinase inhibitors following allo-HCT for chronic myeloid leukemia: A CIBMTR Study.

M. Aljurf, J. Szer, R. Gale, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Myelodysplastic syndromes disable support of human hematopoietic stem and progenitor cells by CD271, VCAM- 1 and CD146 expressing marrow niche cells

Jason R. Myers, Siba El Hussein, M. Azadniv, 2023, bioRxiv.

Myelodysplastic syndromes disable human CD271 + VCAM1 + CD146 + niches supporting normal hematopoietic stem/progenitor cells.

Jason R. Myers, Siba El Hussein, M. Azadniv, 2023, bioRxiv : the preprint server for biology.

Clonal cytopenia of undetermined significance (CCUS)-associated reversion of donor-derived, transient αβ T-cell large granular clonal lymphocytosis, emerging post-transplant in a patient with a history of γδ T-cell large granular lymphocytic leukemia

Z. Oltvai, P. Rothberg, J. Liesveld, 2023, Cold Spring Harbor molecular case studies.

2520 : Involved Field Radiation Therapy Following Autologous Stem Cell Rescue for Hodgkin and Non-Hodgkin Lymphoma - Is it Efficacious?

L. Constine, A. Muhs, J. Liesveld, 2006 .

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) arising in the setting of polycythemia vera (PV): An illustration of the emerging role of flow cytometry analysis in monitoring progression of myeloproliferative neoplasms

W. R. Burack, L. Medeiros, J. Liesveld, 2022, EJHaem.

Effect of stem cell factor on myelopoiesis potential in human Dexter-type culture systems.

V. Broudy, J. Liesveld, C. Abboud, 1995, Experimental Hematology.

Bone Marrow–Derived Mesenchymal Stem Cells From Patients With Systemic Lupus Erythematosus Have a Senescence‐Associated Secretory Phenotype Mediated by a Mitochondrial Antiviral Signaling Protein–Interferon‐β Feedback Loop

J. Liesveld, J. Anolik, N. Meednu, 2017, Arthritis & rheumatology.

Effects of AMD 3100 on Transmigration and Survival of Acute Myelogenous Leukemia Cells

J. Liesveld, Jane L. Liesveld, 2007 .

Stem Cell Enrichment with Selectin Receptors: Mimicking the pH Environment of Trauma

Michael R. King, Michael J. Mitchell, Thong M. Cao, 2013, Sensors.

Mixed Origins: HIV gp120-specific memory develops from pre-existing memory and naïve B cells following vaccination in humans

M. Piepenbrink, J. Liesveld, Christopher Fucile, 2021, bioRxiv.

Effects of the farnesyl transferase inhibitor R115777 on normal and leukemic hematopoiesis

J. Lancet, J. Liesveld, C. Abboud, 2003, Leukemia.

The relative distribution of coronary blood flow in rats with moderate and marked left ventricular hypertrophy

J. Liesveld, M. Laughlin, R. Tomanek, 1980 .

Effects of GM-CSF on Ki67 expression and cell cycle traverse in acute myelogenous leukemia specimens and cell lines.

J. Dipersio, P. Keng, J. Liesveld, 1994, Leukemia research.

In Vitro Insights Into the Influence of Marrow Mesodermal/Mesenchymal Progenitor Cells on Acute Myelogenous Leukemia and Myelodysplastic Syndromes.

J. Liesveld, Jaques Galipeau, 2023, Stem cells.

Efferocytosis by bone marrow mesenchymal stromal cells disrupts osteoblastic differentiation via mitochondrial remodeling

Michael R. Elliott, L. Calvi, J. Liesveld, 2023, Cell death & disease.

Protocol for a pilot randomized controlled trial of a mobile health exercise intervention for older patients with myeloid neoplasms (GO-EXCAP 2).

P. Vertino, J. Liesveld, K. Loh, 2021, Journal of geriatric oncology.

Portable medical orders and end-of-life measures in acute myeloid leukemia and myelodysplastic syndromes

B. Kluger, J. Liesveld, K. Loh, 2021, Blood advances.

Bcl-2 Inhibitor ABT-263 Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cells

J. Liesveld, P. Brookes, C. Jordan, 2012 .

A Role for IL1RAP in Acute Myelogenous Leukemia Stem Cells Following Treatment and Progression

L. Calvi, J. Liesveld, J. Ashton, 2015 .

W. Hiddemann, J. Liesveld, G. Dewald, 2001, American journal of hematology.

Developing and adapting a mobile health exercise intervention for older patients with myeloid neoplasms: A qualitative study.

S. Mohile, I. Kleckner, P. Vertino, 2021, Journal of geriatric oncology.

This information is current as Erythematosus Human and Murine Systemic Lupus Bone Marrow Alters B Cell Development in Neutrophil-Mediated IFN Activation in the

J. Liesveld, J. Knight, E. Baechler, 2013 .

Treatment patterns in low-grade non-Hodgkin's lymphomas: a single institution study.

J. Bennett, J. Liesveld, R. Raubertas, 1991, Medical and pediatric oncology.

One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: value of pretransplant disease status for predicting outcome.

M. A. Tanner, J. Liesveld, C. Abboud, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Use of tamibarotene, a potent and selective RARα agonist, in combination with azacitidine in patients with relapsed and refractory AML with RARA gene overexpression.

N. Rajagopal, T. Cluzeau, S. de Botton, 2023, Leukemia and Lymphoma.

Early Results from a Biomarker-Directed Phase 2 Trial of Sy-1425 in Combination with Azacitidine or Daratumumab in Non-APL Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

J. Cortes, J. Liesveld, A. Raza, 2018, Blood.

A Phase 1/2 Study of Umbralisib Ublituximab and Venetoclax in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

J. Friedberg, J. Liesveld, B. Hill, 2019, Blood.

Analysis of factors that correlate with mucositis in recipients of autologous and allogeneic stem-cell transplants.

L. Constine, J. Liesveld, C. Abboud, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Patients > or = age 40 years undergoing autologous or allogeneic BMT have regimen-related mortality rates and event-free survivals comparable to patients < age 40 years.

J. Dipersio, M. A. Tanner, L. Constine, 1995, Bone marrow transplantation.

Dueling for dual inhibition: Means to enhance effectiveness of PI3K/Akt/mTOR inhibitors in AML.

J. Liesveld, Lauren Herschbein, 2017, Blood reviews.

A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis

I. Yakoub-Agha, M. Aljurf, R. Gale, 2023, Blood advances.

Effect of stromal cell coculture on progenitor cell expansion and myeloid effector function in vitro.

J. Liesveld, C. Abboud, K. Rosell, 1998, Journal of hematotherapy.

Distinct Properties of Leukemia Stem Cells in Primary Refractory Acute Myeloid Leukemia

Jason R. Myers, H. McMurray, L. Calvi, 2015 .

Evolution of acute myelogenous leukemia stem cell properties after treatment and progression.

Jason R. Myers, J. Liesveld, J. Ashton, 2013, Blood.

Management of AML: who do we really cure?

J. Liesveld, 2012, Leukemia research.

Targeting Aberrant Glutathione Metabolism to Eradicate Human Acute Myelogenous Leukemia Cells*

Patricia Greninger, J. Settleman, C. Benes, 2013, The Journal of Biological Chemistry.

Aged marrow macrophages expand platelet-biased hematopoietic stem cells via Interleukin1B.

Michael R. Elliott, Jason R. Myers, A. McDavid, 2019, JCI insight.

Novel mHealth App to Deliver Geriatric Assessment-Driven Interventions for Older Adults With Cancer: Pilot Feasibility and Usability Study

S. Mohile, J. Liesveld, K. Loh, 2018, JMIR cancer.

Outcomes and costs of autologous stem cell mobilization with chemotherapy plus G-CSF versus G-CSF alone

G. Tricot, J. Kanda, J. Liesveld, 2013, Bone Marrow Transplantation.

Vitamin D Receptor Antagonist MeTC7 Inhibits PD-L1

Richard G. Moore, P. Jurutka, N. Dokholyan, 2023, Cancers.

Bendamustine, Bortezomib and Rituximab in Patients (pts) Relapsed/Refractory Indolent and Mantle Cell Non-Hodgkin Lymphoma (NHL): a Multicenter Phase II Clinical Trial.

J. Armitage, J. Vose, J. Friedberg, 2009 .

A phase 1 trial of eltrombopag in patients undergoing stem cell transplantation after total body irradiation.

J. Friedberg, O. Hyrien, L. Constine, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A Phase 2 Study of Fludarabine and Rituximab for the Treatment of Marginal Zone Lymphomas.

J. Friedberg, R. Fisher, D. Neuberg, 2007 .

The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia.

M. Norkin, B. Sandmaier, B. George, 2019, Blood advances.

Patterns and timing of initial relapse in patients subsequently undergoing transplantation for Hodgkin's lymphoma.

J. Friedberg, L. Constine, J. Liesveld, 2009, International journal of radiation oncology, biology, physics.

Patterns and Timing of Failure for Diffuse Large B-Cell Lymphoma After Initial Therapy in a Cohort Who Underwent Autologous Bone Marrow Transplantation for Relapse.

J. Friedberg, L. Constine, J. Liesveld, 2016, International journal of radiation oncology, biology, physics.

Patterns and Timing of Initial Relapse in Patients with Hodgkin’s and Non-Hodgkin’s Lymphoma.

L. Constine, A. Muhs, J. Liesveld, 2006 .

Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia.

A. Zander, J. Szer, M. Horowitz, 2008, Blood.

Obesity Does Not Preclude Safe and Effective Myeloablative Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia (AML) in Adults

M. Pasquini, K. Ballen, J. Liesveld, 2008 .

Long-Lived Plasma Cells Are Contained within the CD19(-)CD38(hi)CD138(+) Subset in Human Bone Marrow.

Ivan V. Gregoretti, E. Walsh, A. Falsey, 2015, Immunity.